|
Parmax Pharma Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
11.41 Cr.
|
P/BV
|
-1.82
|
Book Value (Rs.)
|
-16.77
|
|
52 Week High/Low (Rs.)
|
55/23
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 51.01 | 51.01 | 51.01 | 51.01 | 51.01 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 4.45 | 4.45 | 4.45 | 4.45 | 4.45 |
| Total Share Capital | 4.45 | 4.45 | 4.45 | 4.45 | 4.45 |
| | | | | | |
| Reserves and Surplus | -6.44 | -4.38 | 1.40 | 1.51 | 1.37 |
| Total Reserves and Surplus | -6.44 | -4.38 | 1.40 | 1.51 | 1.37 |
| Total Shareholders Funds | -1.99 | 0.07 | 5.86 | 5.96 | 5.82 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 7.70 | 5.91 | 4.48 | 4.52 | 5.43 |
| Deferred Tax Liabilities [Net] | 0.00 | 0.14 | 0.14 | 0.18 | 0.23 |
| Total Non-Current Liabilities | 7.70 | 6.05 | 4.62 | 4.70 | 5.66 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Trade Payables | 10.22 | 7.39 | 4.66 | 5.52 | 9.92 |
| Other Current Liabilities | 2.24 | 1.60 | 1.50 | 0.86 | 0.49 |
| Short Term Provisions | 0.59 | 0.23 | 0.97 | 0.94 | 0.84 |
| Total Current Liabilities | 13.04 | 9.21 | 7.14 | 7.32 | 11.25 |
| | | | | | |
| Total Capital And Liabilities | 18.75 | 15.33 | 17.61 | 17.97 | 22.73 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 7.97 | 9.27 | 9.50 | 10.44 | 10.84 |
| Capital Work-In-Progress | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
| Fixed Assets | 7.97 | 9.38 | 9.50 | 10.44 | 10.84 |
| Non-Current Investments | 0.40 | 0.00 | 0.00 | 0.00 | 0.20 |
| Deferred Tax Assets [Net] | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Loans And Advances | 0.18 | 0.18 | 0.19 | 0.18 | 0.16 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.40 | 0.79 | 1.19 |
| Total Non-Current Assets | 8.75 | 9.56 | 10.08 | 11.42 | 12.39 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 3.31 | 2.39 | 4.31 | 2.85 | 3.95 |
| Trade Receivables | 1.28 | 1.82 | 0.62 | 0.68 | 1.65 |
| Cash And Cash Equivalents | 0.09 | 0.05 | 0.41 | 1.05 | 2.55 |
| Short Term Loans And Advances | 5.32 | 1.51 | 2.19 | 1.98 | 2.19 |
| Total Current Assets | 10.00 | 5.77 | 7.53 | 6.56 | 10.34 |
| | | | | | |
| Total Assets | 18.75 | 15.33 | 17.61 | 17.97 | 22.73 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 0.00 | 1.00 | 1.00 | 0.00 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.40 | 0.00 | 0.00 | 0.00 | 0.20 |
